Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Latest SPAC News: Tidjane Thiam’s SPAC in talks with Credijusto, and packaging-technology firm Footprint eyes SPAC deal with Gores
Tidjane Thiam’s SPAC in Talks With Mexican Fintech Credijusto
Tidjane Thiam’s SPAC (Freedom Acquisition I Corp. NYSE:FACT) is in talks with Mexican fintech group Credijusto and Latin American corporate data provider CIAL Dun & Bradstreet with the aim of listing the companies in New York later this year, according to the Financial Times.
The deal could value the combined companies at around $1.5 billion.
READPackaging-Technology Firm Footprint Said in Gores SPAC Talks
Plant-based fiber manufacturer Footprint is in talks to go public through a merger with blank-check firm Gores Holdings VII Inc. (Nasdaq:GSEV), according to Bloomberg.
A transaction is set to value the combined entity at as much as $3 billion.
READ
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...